LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

NCT01828112 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

231

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Ceritinib
DRUG: Pemetrexed
DRUG: Docetaxel

Sponsor

Novartis Pharmaceuticals